 | • レポートコード：B-GIR09D4269 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ロミプロスチムの世界市場について調べ、まとめました。種類別セグメントは、250μg/ 0.5 mL、500μg/ 1 mL等、用途別セグメントは、成人、小児患者等に区分しました。ロミプロスチムの世界市場概観、企業動向、企業別ロミプロスチムシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ロミプロスチムの市場概観 ・ロミプロスチムの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ロミプロスチムの企業別販売動向、市場シェア、市場集中度、競争動向 ・ロミプロスチムの世界市場規模 ・ロミプロスチムの北米市場分析（アメリカ、カナダ、メキシコ等） ・ロミプロスチムのアメリカ市場規模推移 ・ロミプロスチムのカナダ市場規模推移 ・ロミプロスチムのメキシコ市場規模推移 ・ロミプロスチムのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ロミプロスチムのドイツ市場規模推移 ・ロミプロスチムのイギリス市場規模推移 ・ロミプロスチムのロシア市場規模推移 ・ロミプロスチムのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ロミプロスチムの日本市場規模推移 ・ロミプロスチムの中国市場規模推移 ・ロミプロスチムの韓国市場規模推移 ・ロミプロスチムのインド市場規模推移 ・ロミプロスチムの東南アジア市場規模推移 ・ロミプロスチムの南米市場分析（ブラジル、アルゼンチン等） ・ロミプロスチムの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ロミプロスチムの種類別分析/販売量、売上、市場シェア（250μg/ 0.5 mL、500μg/ 1 mL） ・ロミプロスチムの用途別分析/市場規模（成人、小児患者） ・ロミプロスチムの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ロミプロスチムの販売チャネル・代理店・貿易業者・ディーラー分析 |
Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production.
Scope of the Report:
The global Romiplostim market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Romiplostim.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Romiplostim market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Romiplostim market by product type and applications/end industries.
Market Segment by Companies, this report covers
AMGEN
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
250 μg/0.5 mL
500 μg/1 mL
Market Segment by Applications, can be divided into
Adults
Pediatric patients
Table of Contents
1 Romiplostim Market Overview
1.1 Product Overview and Scope of Romiplostim
1.2 Classification of Romiplostim by Types
1.2.1 Global Romiplostim Revenue Comparison by Types (2019-2024)
1.2.2 Global Romiplostim Revenue Market Share by Types in 2018
1.2.3 250 μg/0.5 mL
1.2.4 500 μg/1 mL
1.3 Global Romiplostim Market by Application
1.3.1 Global Romiplostim Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Global Romiplostim Market by Regions
1.4.1 Global Romiplostim Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Romiplostim Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Romiplostim Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Romiplostim Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Romiplostim Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Romiplostim Status and Prospect (2014-2024)
1.5 Global Market Size of Romiplostim (2014-2024)
2 Manufacturers Profiles
2.1 AMGEN
2.1.1 Business Overview
2.1.2 Romiplostim Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AMGEN Romiplostim Revenue, Gross Margin and Market Share (2017-2018)
3 Global Romiplostim Market Competition, by Players
3.1 Global Romiplostim Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Romiplostim Players Market Share
3.2.2 Top 10 Romiplostim Players Market Share
3.3 Market Competition Trend
4 Global Romiplostim Market Size by Regions
4.1 Global Romiplostim Revenue and Market Share by Regions
4.2 North America Romiplostim Revenue and Growth Rate (2014-2019)
4.3 Europe Romiplostim Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Romiplostim Revenue and Growth Rate (2014-2019)
4.5 South America Romiplostim Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Romiplostim Revenue and Growth Rate (2014-2019)
5 North America Romiplostim Revenue by Countries
5.1 North America Romiplostim Revenue by Countries (2014-2019)
5.2 USA Romiplostim Revenue and Growth Rate (2014-2019)
5.3 Canada Romiplostim Revenue and Growth Rate (2014-2019)
5.4 Mexico Romiplostim Revenue and Growth Rate (2014-2019)
6 Europe Romiplostim Revenue by Countries
6.1 Europe Romiplostim Revenue by Countries (2014-2019)
6.2 Germany Romiplostim Revenue and Growth Rate (2014-2019)
6.3 UK Romiplostim Revenue and Growth Rate (2014-2019)
6.4 France Romiplostim Revenue and Growth Rate (2014-2019)
6.5 Russia Romiplostim Revenue and Growth Rate (2014-2019)
6.6 Italy Romiplostim Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Romiplostim Revenue by Countries
7.1 Asia-Pacific Romiplostim Revenue by Countries (2014-2019)
7.2 China Romiplostim Revenue and Growth Rate (2014-2019)
7.3 Japan Romiplostim Revenue and Growth Rate (2014-2019)
7.4 Korea Romiplostim Revenue and Growth Rate (2014-2019)
7.5 India Romiplostim Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Romiplostim Revenue and Growth Rate (2014-2019)
8 South America Romiplostim Revenue by Countries
8.1 South America Romiplostim Revenue by Countries (2014-2019)
8.2 Brazil Romiplostim Revenue and Growth Rate (2014-2019)
8.3 Argentina Romiplostim Revenue and Growth Rate (2014-2019)
8.4 Colombia Romiplostim Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Romiplostim by Countries
9.1 Middle East and Africa Romiplostim Revenue by Countries (2014-2019)
9.2 Saudi Arabia Romiplostim Revenue and Growth Rate (2014-2019)
9.3 UAE Romiplostim Revenue and Growth Rate (2014-2019)
9.4 Egypt Romiplostim Revenue and Growth Rate (2014-2019)
9.5 Nigeria Romiplostim Revenue and Growth Rate (2014-2019)
9.6 South Africa Romiplostim Revenue and Growth Rate (2014-2019)
10 Global Romiplostim Market Segment by Type
10.1 Global Romiplostim Revenue and Market Share by Type (2014-2019)
10.2 Global Romiplostim Market Forecast by Type (2019-2024)
10.3 250 μg/0.5 mL Revenue Growth Rate (2014-2024)
10.4 500 μg/1 mL Revenue Growth Rate (2014-2024)
11 Global Romiplostim Market Segment by Application
11.1 Global Romiplostim Revenue Market Share by Application (2014-2019)
11.2 Romiplostim Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2014-2019)
11.4 Pediatric patients Revenue Growth (2014-2019)
12 Global Romiplostim Market Size Forecast (2019-2024)
12.1 Global Romiplostim Market Size Forecast (2019-2024)
12.2 Global Romiplostim Market Forecast by Regions (2019-2024)
12.3 North America Romiplostim Revenue Market Forecast (2019-2024)
12.4 Europe Romiplostim Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Romiplostim Revenue Market Forecast (2019-2024)
12.6 South America Romiplostim Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Romiplostim Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Romiplostim Picture
Table Product Specifications of Romiplostim
Table Global Romiplostim and Revenue (Million USD) Market Split by Product Type
Figure Global Romiplostim Revenue Market Share by Types in 2018
Figure 250 μg/0.5 mL Picture
Figure 500 μg/1 mL Picture
Table Global Romiplostim Revenue (Million USD) by Application (2014-2024)
Figure Romiplostim Revenue Market Share by Applications in 2018
Figure Adults Picture
Figure Pediatric patients Picture
Table Global Market Romiplostim Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Romiplostim Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Romiplostim Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Romiplostim Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Romiplostim Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Romiplostim Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Romiplostim Revenue (Million USD) and Growth Rate (2014-2024)
Table AMGEN Basic Information, Manufacturing Base and Competitors
Table AMGEN Romiplostim Type and Applications
Table AMGEN Romiplostim Revenue, Gross Margin and Market Share (2017-2018)
Table Global Romiplostim Revenue (Million USD) by Players (2014-2019)
Table Global Romiplostim Revenue Share by Players (2014-2019)
Figure Global Romiplostim Revenue Share by Players in 2017
Figure Global Romiplostim Revenue Share by Players in 2018
Figure Global Top 5 Players Romiplostim Revenue Market Share in 2018
Figure Global Top 10 Players Romiplostim Revenue Market Share in 2018
Figure Global Romiplostim Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Romiplostim Revenue (Million USD) by Regions (2014-2019)
Table Global Romiplostim Revenue Market Share by Regions (2014-2019)
Figure Global Romiplostim Revenue Market Share by Regions (2014-2019)
Figure Global Romiplostim Revenue Market Share by Regions in 2018
Figure North America Romiplostim Revenue and Growth Rate (2014-2019)
Figure Europe Romiplostim Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Romiplostim Revenue and Growth Rate (2014-2019)
Figure South America Romiplostim Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Romiplostim Revenue and Growth Rate (2014-2019)
Table North America Romiplostim Revenue by Countries (2014-2019)
Table North America Romiplostim Revenue Market Share by Countries (2014-2019)
Figure North America Romiplostim Revenue Market Share by Countries (2014-2019)
Figure North America Romiplostim Revenue Market Share by Countries in 2018
Figure USA Romiplostim Revenue and Growth Rate (2014-2019)
Figure Canada Romiplostim Revenue and Growth Rate (2014-2019)
Figure Mexico Romiplostim Revenue and Growth Rate (2014-2019)
Table Europe Romiplostim Revenue (Million USD) by Countries (2014-2019)
Figure Europe Romiplostim Revenue Market Share by Countries (2014-2019)
Figure Europe Romiplostim Revenue Market Share by Countries in 2018
Figure Germany Romiplostim Revenue and Growth Rate (2014-2019)
Figure UK Romiplostim Revenue and Growth Rate (2014-2019)
Figure France Romiplostim Revenue and Growth Rate (2014-2019)
Figure Russia Romiplostim Revenue and Growth Rate (2014-2019)
Figure Italy Romiplostim Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Romiplostim Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Romiplostim Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Romiplostim Revenue Market Share by Countries in 2018
Figure China Romiplostim Revenue and Growth Rate (2014-2019)
Figure Japan Romiplostim Revenue and Growth Rate (2014-2019)
Figure Korea Romiplostim Revenue and Growth Rate (2014-2019)
Figure India Romiplostim Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Romiplostim Revenue and Growth Rate (2014-2019)
Table South America Romiplostim Revenue by Countries (2014-2019)
Table South America Romiplostim Revenue Market Share by Countries (2014-2019)
Figure South America Romiplostim Revenue Market Share by Countries (2014-2019)
Figure South America Romiplostim Revenue Market Share by Countries in 2018
Figure Brazil Romiplostim Revenue and Growth Rate (2014-2019)
Figure Argentina Romiplostim Revenue and Growth Rate (2014-2019)
Figure Colombia Romiplostim Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Romiplostim Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Romiplostim Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Romiplostim Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Romiplostim Revenue Market Share by Countries in 2018
Figure Saudi Arabia Romiplostim Revenue and Growth Rate (2014-2019)
Figure UAE Romiplostim Revenue and Growth Rate (2014-2019)
Figure Egypt Romiplostim Revenue and Growth Rate (2014-2019)
Figure Nigeria Romiplostim Revenue and Growth Rate (2014-2019)
Figure South Africa Romiplostim Revenue and Growth Rate (2014-2019)
Table Global Romiplostim Revenue (Million USD) by Type (2014-2019)
Table Global Romiplostim Revenue Share by Type (2014-2019)
Figure Global Romiplostim Revenue Share by Type (2014-2019)
Figure Global Romiplostim Revenue Share by Type in 2019
Table Global Romiplostim Revenue Forecast by Type (2019-2024)
Figure Global Romiplostim Market Share Forecast by Type (2019-2024)
Figure Global 250 μg/0.5 mL Revenue Growth Rate (2014-2019)
Figure Global 500 μg/1 mL Revenue Growth Rate (2014-2019)
Table Global Romiplostim Revenue by Application (2014-2019)
Table Global Romiplostim Revenue Share by Application (2014-2019)
Figure Global Romiplostim Revenue Share by Application (2014-2019)
Figure Global Romiplostim Revenue Share by Application in 2019
Table Global Romiplostim Revenue Forecast by Application (2019-2024)
Figure Global Romiplostim Market Share Forecast by Application (2019-2024)
Figure Global Adults Revenue Growth Rate (2014-2019)
Figure Global Pediatric patients Revenue Growth Rate (2014-2019)
Figure Global Romiplostim Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Romiplostim Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Romiplostim Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Romiplostim Revenue Market Forecast (2019-2024)
Figure Europe Romiplostim Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Romiplostim Revenue Market Forecast (2019-2024)
Figure South America Romiplostim Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Romiplostim Revenue Market Forecast (2019-2024)
世界のエトラビリン市場予測（～2024年） Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etrav…- 世界のルフィナミド市場予測（～2024年） Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders. Scope of the Report: The global Rufinamide market is valued at xx million USD in 2018 and is expected to reach xx million USD …
- 世界のオロパタジン眼科市場予測（～2024年） Olopatadine eye drops (Pazeo, Patanol, Pataday) are used to treat itchy eyes caused by allergies. Scope of the Report: The global Olopatadine Ophthalmic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 20…
- 世界の小児慢性副鼻腔炎治療市場予測（～2024年） Pediatric chronic Rhinosinusitis is one of the major and common disorder among infants with significant morbidity. Its diagnosis involves sinus symptoms, with prolonged duration requiring standard medical therapy for more than 90 days. The main causative factors for pediatric chronic rhinosinusitis …
- 世界のプレリキサフォー市場予測（～2024年） Plerixafor (INN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients into the bloodstream. Scope of the Report: The global Plerixafor market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, gro…